Ultralife Co.

Ultralife reported a Q1 2026 net loss of $0.03 per share versus an expected $0.15 and revenue of $47.4 million compared with forecasted $52.4 million. Operational disruptions, production shutdowns and higher costs weighed on the result; adjusted EBITDA fell by about 40.7%. The stock lost 12.77% in premarket trading, while the company reported a record order backlog of $115.1 million and the outlook for 2026/2027 still anticipates negative earnings. » More on de.investing.com

Had $10,000 been invested in Ultralife Batteries on the reference date one year ago (closing price then $4.89), the investor would now hold 2,044.990 shares at the latest closing price of $6.84, worth $13,987.73, representing a 39.88% increase in value. Ultralife Batteries most recently reported a market capitalization of $112.47 million. Figures do not take stock splits or dividends into account. » More on finanzen.net

Ultralife reported EPS of $0.45 for Q4 2025, beating the $0.24 expectation, while revenue of $48.5 million fell short of the projected $57 million. The battery and energy products segment and the medical-technology business grew significantly, while the communications segment collapsed due to delayed government orders. A non-cash impairment of $12.2 million weighed on net income, but adjusted EBITDA rose 46.2%. Management expects further EPS growth and forecasts $0.84 for Q1 2026 and $0.86 for Q2 2026. » More on de.investing.com

Ultralife filed a Form 12b-25 with the SEC and postponed the filing of its Q3 financial report because of the system transition following the acquisition of Electrochem. The transition agreement with Integer ended in the third quarter, requiring more time to finalize the quarter’s results and for review by independent auditors. The company expects to file the Form 10-Q by November 17, 2025, but reports strong liquidity with a current ratio of 3.31. Ultralife also reported weaker-than-expected Q2 results and has changed its auditor to Withum. » More on de.investing.com

If someone had invested $10,000 in Ultralife Batteries three years ago, they would now hold 2,016.129 shares and their portfolio value would be $13,608.87 (closing share price on Sept. 3, 2025: $6.75). That corresponds to a price gain of 36.09 percent. Ultralife Batteries is most recently quoted with a market value of $116.49 million; stock splits and dividends were not taken into account in the calculation. » More on finanzen.net